University of Ulm: Clinical Trials

207 trials sponsored by University of Ulm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

109 completed, 36 unknown, 30 recruiting, 13 terminated. 77 Not applicable, 43 Phase 2, 24 Phase 3, 12 Phase 4, 8 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable77Completed 44, Unknown 18, Recruiting 6, Active not recruiting 5, Not yet recruiting 2, Suspended 1, Terminated 1
Phase 243Completed 25, Terminated 6, Unknown 5, Active not recruiting 3, Recruiting 3, Not yet recruiting 1
Phase 324Completed 14, Terminated 3, Unknown 3, Active not recruiting 2, Recruiting 1, Withdrawn 1
Phase 412Completed 8, Unknown 2, Terminated 1, Withdrawn 1
Phase 18Completed 5, Terminated 2, Unknown 1

Follow University of Ulm: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
Temozolomide, Disulfiram, Copper - Glioblastoma Multiforme
Phase 2Not yet recruitingOlympion Medical Center322027-01-012025-05-25
Glucose-Level During Endurance Exercise
Standardized military march - Glucose Metabolism
RecruitingUniversity of Ulm1002026-05-052026-05-11
The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight
Spiroergometer test with intranasal insulin spray, Spiroergometer test with intranasal placebo spray - Insulin Sensitivity
Not applicableNot yet recruitingUniversity of Ulm82026-04-012026-03-16
Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNA
Metabolic and epigenetic characterization of parents ans fetuses - Gestational Diabetes Mellitus (GDM)
RecruitingUniversity of Ulm802026-03-302026-04-07
Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
Alzheimer Disease, Dementia With Lewy Bodies (DLB)
Enrolling by invitationFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau17992026-02-192026-02-23
Impact of Thyroid Hormones on Human Glucose and Energy Metabolism
Oral Glucose Tolerance Test - Graves Disease, Thyroid Cancer
Not applicableRecruitingUniversity of Ulm602026-02-042026-02-13
Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
Major Depressive Disorder (MDD), Schizophenia Disorder
Enrolling by invitationFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau13102026-02-012026-04-24
Disentangling the Effect of Brain Insulin Resistance on Brain Health
Diabetes Type 2, Diabetes Type 1
RecruitingHenrik Bo Wiberg Larsson1502026-01-012026-02-25
International Genetic Obesity Registry
Genetic Obesity
RecruitingUniversity of Ulm50002025-11-172025-12-22
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
RecruitingUniversity of Ulm1402025-08-272025-09-11
Understanding Individual Variability in Neuronal Signal Transmission to Target Organs in Health and Disease
Oral glucose tolerance test with double-tracer dilution and atropine infusion, Oral glucose tolerance test with double-tracer dilution and saline infusion (placebo) - Autonomic Function
Not applicableRecruitingUniversity of Ulm522025-05-142025-07-10
Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
Venetoclax; Rituximab, DRC - Waldenstrom Macroglobulinemia, Treatment Naive
Phase 2RecruitingChristian Buske802025-03-212026-05-05
Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis
100% of individual calory requirement, 120% of individual calory requirement - Amyotrophic Lateral Sclerosis (ALS)
Not applicableRecruitingUniversity of Ulm762025-03-012026-05-06
Magnetic Resonance Imaging in Metabolic Diseases
Metabolic Diseases
RecruitingUniversity of Ulm1262025-02-082026-02-13
High Versus Low Pneumoperitoneum PressUre for Parenchymal Transection in Minimally Invasive Major Liver Surgery
High Pressure Pneumoperitoneum, Low Pressure Pneumoperitoneum - Liver Surgery, Minimal Invasive Surgery
Not applicableNot yet recruitingUniversity Hospital Heidelberg1322025-01-012025-01-13
The Importance of Insulin Action in the Brain for the Immune System During Physical Activity
Spiroergometer test with intranasal insulin spray, Spiroergometer test with intranasal placebo spray - Insulin Sensitivity
Not applicableActive not recruitingUniversity of Ulm202024-12-152025-12-10
Fertility Protection for Children, Adolescents and Young Adults
Stem Cell Transplant, Stem Cell Transplantation
RecruitingUniversity of Ulm20002024-12-092025-01-16
Perturbation-Based Treadmill Training to Prevent Unrecovered Falls in Geriatric Patients
Conventional Treadmill Walking (CTT), Perturbation-Based Balance Training (PBT) - Fall Prevention, Exercise
Not applicableRecruitingUniversity of Oldenburg3962024-11-252025-05-14
Physiological Reaction After Food Intake
Wearable - Physiological Reactivity to Cues
Not applicableActive not recruitingUniversity of Ulm362024-11-122025-12-03
Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease
Prednisolone, Placebo - Osteoporosis Secondary
Phase 2CompletedOdense University Hospital362024-11-042026-10-20

Showing 20 of 207. Sign in to see all of them.

Conditions studied

Leukemia, Myeloid, Acute (20)  ·  Amyotrophic Lateral Sclerosis (9)  ·  Premature Birth (8)  ·  Coronary Artery Disease (7)  ·  Sepsis (7)  ·  Critical Illness (6)  ·  Motor Activity (6)  ·  Cognitive Dysfunction (5)  ·  Infections (5)  ·  Neoplasms (5)  ·  Social Stigma (5)  ·  Atrial Fibrillation (4)  ·  COVID-19 (4)  ·  Colorectal Neoplasms (4)  ·  Glioblastoma (4)

Interventions

Cytarabine (12)  ·  Daunorubicin (6)  ·  Idarubicin (6)  ·  Etoposide (5)  ·  Rituximab (5)  ·  Mitoxantrone (4)  ·  Glucose Tolerance Test (3)  ·  Tretinoin (3)  ·  venetoclax (3)  ·  Azacitidine (2)  ·  Bortezomib (2)  ·  Cyclophosphamide (2)  ·  Dasatinib (2)  ·  Dexamethasone (2)  ·  Disulfiram (2)

Countries

Germany (177)  ·  Austria (22)  ·  Netherlands (11)  ·  France (10)  ·  United Kingdom (9)  ·  Ireland (8)  ·  Italy (8)  ·  Spain (8)  ·  Belgium (6)  ·  Greece (6)  ·  United States (5)  ·  Canada (4)  ·  Norway (4)  ·  Sweden (4)  ·  Denmark (3)

Top investigators

Martin Heni, MD (6)  ·  Christian Buske, MD (4)  ·  Hartmut Doehner, MD (4)  ·  Manfred Weiss, MD, MBA (4)  ·  Manuel B Schmid, Dr. med. (4)  ·  Johannes Hebebrand, Prof. Dr. med. (3)  ·  Lutz Goldbeck, Ph.D. (3)  ·  Manfred Weiss, MD (3)  ·  Thomas Seufferlein, Prof. Dr. (3)  ·  Albert C. Ludolph, MD, Prof. (2)  ·  Anup C Katheria, MD (2)  ·  Axel R Franz, MD (2)  ·  Christian Buske, Prof. Dr. (2)

Results publications

PMID 19602710, PMID 21343560, PMID 22965967, PMID 23987123, PMID 24251360, PMID 28063245, PMID 29720733, PMID 38378503, PMID 39773175, PMID 11015511, PMID 11749299, PMID 17766527, PMID 18676544, PMID 19029129, PMID 19059939, PMID 19137363, PMID 19771175, PMID 20421455, PMID 20805454, PMID 21199047, PMID 21242187, PMID 21282130, PMID 21343153, PMID 21372155, PMID 21386111, PMID 21484192, PMID 21670448, PMID 21829612, PMID 22121824, PMID 22189340, PMID 22244896, PMID 22339896, PMID 22715372, PMID 23479227, PMID 23776701, PMID 23863898, PMID 24251363, PMID 24335498, PMID 24344045, PMID 24456998, PMID 24797300, PMID 25270908, PMID 25454938, PMID 25700037, PMID 26235374, PMID 26248353, PMID 26479969, PMID 26497391, PMID 26556956, PMID 26614707

NIH funding

2009 (3), 2018 (3), 2017 (2), 2023 (2), R01HD088646 (2), 2008 (1), 2014 (1), 2016 (1)